KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShares Repurchased
Ratios

Zoetis (ZTS) EBIAT (2016 - 2026)

Zoetis has reported EBIAT over the past 14 years, most recently at $603.0 million for Q4 2025.

  • Quarterly EBIAT rose 3.79% to $603.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.7 billion through Dec 2025, up 7.09% year-over-year, with the annual reading at $2.7 billion for FY2025, 7.52% up from the prior year.
  • EBIAT was $603.0 million for Q4 2025 at Zoetis, down from $721.0 million in the prior quarter.
  • Over five years, EBIAT peaked at $721.0 million in Q3 2025 and troughed at $416.0 million in Q4 2021.
  • The 5-year median for EBIAT is $587.5 million (2022), against an average of $583.2 million.
  • Year-over-year, EBIAT surged 35.81% in 2021 and then decreased 7.24% in 2023.
  • A 5-year view of EBIAT shows it stood at $416.0 million in 2021, then rose by 10.58% to $460.0 million in 2022, then grew by 14.57% to $527.0 million in 2023, then rose by 10.25% to $581.0 million in 2024, then grew by 3.79% to $603.0 million in 2025.
  • Per Business Quant, the three most recent readings for ZTS's EBIAT are $603.0 million (Q4 2025), $721.0 million (Q3 2025), and $718.0 million (Q2 2025).